FROM PUBLIC EVENTS · 2026-11-15

Current stage

  1. Discovery · preclinical
  2. Early clinical · first deals
  3. Late clinical · capacity
  4. Commercial · sales
  1. Global approvals · expansion
  2. M&A · integration
  3. Pipeline reshaping

Late clinical · capacity Expanding production with a construction contract for a second plant dedicated to long-acting injectables.

  • Construction contract for the second long-acting injectable plant in Osong. Source
  • Building permit for the new Osong plant. Source

Roles often seen at this stageManufacturing & MSAT · Quality QA & QC · Research & development

Companies at the same stage and their people flow →

← Company library
Korea / Company briefSources checked 2026-11-15

Peptron

A company with drug-delivery technology that makes peptide medicines long-acting, building a dedicated long-acting injectable plant in Osong.

Long-acting injectable platform

Technology platform

Drug-delivery platform for long-acting peptide injectables such as once-monthly dosing.

Osong long-acting injectable plant

Stage unconfirmed

Second plant for long-acting injectables being built in Osong, targeting up to 10 million vials a year.

Completion reported

Signed the construction contract for its second plant in Osong.

Official role guide

Peptron careers

Current availability unconfirmed

Observed 2026-11-15

Work
Unconfirmed — The official careers page could not be confirmed.
Experience & requirements
Unconfirmed — The official careers page could not be confirmed.

Information from a role guide does not establish a current vacancy.

Sources & coverage 2

A brief based on selected official material, not an exhaustive product or vacancy list.

  1. "글로벌 사업화 대비"…펩트론, 제2공장 시공계약 ↗뉴시스 · Published 2026-09-03 · Sources checked 2026-11-15 · Original unavailable
  2. 펩트론, 오송에 장기지속형 의약품 신공장 건축 승인 ↗한국경제 · Published 2025-12-16 · Sources checked 2026-11-15 · Original unavailable